Cancer drug trial halted over stability concerns; Philippines officials score fakes bust;

> Helix BioPharma's experimental cancer treatment was placed on clinical hold by the FDA, based on product stability concerns. Story

> The National Bureau of Investigation of the Philippines has made one arrest and seized about a half-million dollars' worth of fake medicines imported from India, Pakistan and Singapore. Article

Special Report:Top 10 Pharma CEO salaries of 2009. Report

> Hebei Aoxing API Pharmaceutical Company, a joint venture of Aoxing Pharma and Macfarlan Smith, has received a manufacturing licence from the China State Food and Drug Administration. Aoxing release

> A "tantalizing glimpse" of pharma company earnings is available from the spending breakdown of the U.K.'s Department of Health. Story

> India is considering whether to grant autonomous status to its three public-sector vaccine production units. Item

Special Report: Top 5 Game-Changing Drug Delivery Technologies. Report

> VR Laboratories, a start-up natural pharmaceutical company, is considering a site in Fort Myers, FL, for its headquarters. Article

> Hospira has named Frans Dubois to the new position of senior VP for Quality. Hospira release

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)